Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BARZILAI skin sensitization potential evaluation
RBR-8sv755Phase 1Terminated
- Sponsor
- Infinant Health
- Start
- Sep 2020
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in None, sponsored by Infinant Health. Started Sep 2020; status: terminated.
Beyond the preview
Go deeper on RBR-8sv755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8sv755.